| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |